Modeling the Impact of Colorectal Cancer Screening and Timely Follow-Up Colonoscopy: Recent Data from the Cancer Intervention and Surveillance Modeling Network (CISNET)
Explore Findings from a New Modeling Study on Colorectal Cancer Screening and Outcomes
This Blue Star Conversation was held on Tuesday, April 15th and titled: “Modeling the impact of colorectal cancer screening and timely follow-up colonoscopy: Recent data from the Cancer Intervention and Surveillance Modeling Network (CISNET).” The program featured a presentation highlighting the yet-to-be-published data from CISNET, a consortium of NCI-sponsored investigators that includes modeling to improve our understanding of the impact of cancer control interventions on population trends in incidence and mortality. Participants also learned about Fight Colorectal Cancer’s (Fight CRC’s) new CRC Care Initiative and how the data is being used to inform this effort. After the presentation, participants had an opportunity to discuss implications of the data, including how findings can be used to inform CRC prevention and control strategies.
Speakers:
- John M. Inadomi, MD, University of Utah Health
- Amy Knudsen, PhD, Massachusetts General Hospital
- Carolyn M. Rutter, PhD, Fred Hutch Cancer Center
- Molly McDonnell, Fight Colorectal Cancer (moderator)
A recording of the presentation is not available due to the yet-to-be-published data presented.
Explore More

Blue Star Conversation: April 15, 2025
This Blue Star Conversation covered, "Modeling the Impact of Colorectal Cancer Screening and Timely Follow-Up Colonoscopy: Recent Data from the Cancer Intervention and Surveillance Modeling Network (CISNET)"

ACS Webinar: Cancer Prevention and Screening for Community Health Centers
This webinar focused on health centers and covered the current state of colorectal cancer, the urgent need for screening patients age 45-55, and a review of tools and resources available.

Clinician’s Reference: Stool-Based Tests for Colorectal Cancer Screening
This revised resource is designed to introduce (or reintroduce) clinicians to the value of stool-based testing for colorectal cancer.